Medicine & Life Sciences
Glucose
85%
Peptides
69%
Glucagon-Like Peptide 1
64%
xenin 25
64%
gastric inhibitory polypeptide receptor
58%
Hypoglycemic Agents
44%
Insulin
42%
Insulin Secretion
31%
Fats
30%
Pro(3)-glucose-dependent insulinotropic polypeptide
28%
Incretins
27%
Obesity
27%
Gastric Inhibitory Polypeptide
26%
Dipeptidyl Peptidase 4
24%
Insulin Resistance
22%
Liraglutide
22%
Oxyntomodulin
21%
Glucagon-Like Peptide-1 Receptor
21%
xenin-8
20%
pro-glucose-dependent insulinotropic polypeptide
19%
Exenatide
19%
Homeostasis
17%
Neuronal Plasticity
15%
Type 2 Diabetes Mellitus
14%
exendin (9-39)
14%
Glucagon
13%
Hormones
12%
Islets of Langerhans
11%
High Fat Diet
11%
Body Weight
11%
Insulin-Secreting Cells
10%
Therapeutics
10%
glucagon-like peptide-1 (9-36)-amide
10%
glucagon-like peptide 1 (7-36)amide
9%
Cognition
9%
D-Ser2-oxyntomodulin
8%
Streptozocin
8%
Sitagliptin Phosphate
7%
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
7%
Injections
7%
Long-Term Potentiation
7%
Memory
7%
Eating
6%
Gene Expression
6%
Glucose Intolerance
6%
Alzheimer Disease
6%
Venoms
6%
Cyclic AMP
6%
Peptide Fragments
6%
Gastrins
6%
Chemistry
Insulinotropic
100%
Insulin Derivative
56%
Polypeptide
43%
Glucose
35%
Glucagon-Like Peptide 1
24%
Fat
18%
Antidiabetic Agent
16%
Metabolic
16%
Exendin-4
13%
Peptide
13%
Agent Interacting With Transmitter, Hormone or Drug Receptor
11%
Oxyntomodulin
10%
Plasma
10%
Agonist
9%
Glucagon
8%
Hormone
8%
Neurotensin
7%
Glycemic
7%
Weight
6%
Liraglutide
6%
Venom
6%
Twice Daily
5%
Bioactivity
5%